JPWO2020243135A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020243135A5 JPWO2020243135A5 JP2021570274A JP2021570274A JPWO2020243135A5 JP WO2020243135 A5 JPWO2020243135 A5 JP WO2020243135A5 JP 2021570274 A JP2021570274 A JP 2021570274A JP 2021570274 A JP2021570274 A JP 2021570274A JP WO2020243135 A5 JPWO2020243135 A5 JP WO2020243135A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- compound
- membered monocyclic
- ocf
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962853533P | 2019-05-28 | 2019-05-28 | |
| EP19176933.0 | 2019-05-28 | ||
| US62/853,533 | 2019-05-28 | ||
| EP19176933 | 2019-05-28 | ||
| CNPCT/CN2020/085720 | 2020-04-20 | ||
| CN2020085720 | 2020-04-20 | ||
| PCT/US2020/034643 WO2020243135A1 (en) | 2019-05-28 | 2020-05-27 | Fused heterocyclic derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022535734A JP2022535734A (ja) | 2022-08-10 |
| JPWO2020243135A5 true JPWO2020243135A5 (ru) | 2023-06-05 |
Family
ID=71741889
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021570274A Pending JP2022535734A (ja) | 2019-05-28 | 2020-05-27 | 縮合複素環誘導体 |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP3976617A1 (ru) |
| JP (1) | JP2022535734A (ru) |
| KR (1) | KR20220012913A (ru) |
| CN (1) | CN113906028A (ru) |
| AU (1) | AU2020285718A1 (ru) |
| BR (1) | BR112021022889A8 (ru) |
| CA (1) | CA3138168A1 (ru) |
| CL (1) | CL2021003155A1 (ru) |
| CO (1) | CO2021016433A2 (ru) |
| CR (1) | CR20210666A (ru) |
| IL (1) | IL288322A (ru) |
| JO (1) | JOP20210313A1 (ru) |
| MA (1) | MA56043A (ru) |
| MX (1) | MX2021014575A (ru) |
| PE (1) | PE20220767A1 (ru) |
| SG (1) | SG11202113167QA (ru) |
| WO (1) | WO2020243135A1 (ru) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022116999A1 (en) * | 2020-12-02 | 2022-06-09 | Janssen Sciences Ireland Unlimited Company | Fused heterocyclic derivatives and their use in the treatment of hbv infection |
| EP4255571A1 (en) * | 2020-12-02 | 2023-10-11 | Janssen Sciences Ireland Unlimited Company | Fused heterocyclic derivatives and their use in the treatment of hbv infection |
| WO2022116998A1 (en) * | 2020-12-02 | 2022-06-09 | Janssen Sciences Ireland Unlimited Company | Fused heterocyclic derivatives as hbv inhibitors |
| UY39793A (es) * | 2021-06-02 | 2022-11-30 | Janssen Sciences Ireland Unlimited Co | Derivados heterocíclicos condensados |
| TW202313609A (zh) | 2021-06-02 | 2023-04-01 | 愛爾蘭商健生科學愛爾蘭無限公司 | 稠合雜環衍生物(二) |
| WO2024114709A1 (en) * | 2022-12-01 | 2024-06-06 | Janssen Sciences Ireland Unlimited Company | A crystal form of a fused heterocycle derivative compound |
| WO2024140851A1 (zh) * | 2022-12-28 | 2024-07-04 | 上海维申医药有限公司 | 一类Toll样受体抑制剂及其制备和应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2993174A1 (en) * | 2014-09-08 | 2016-03-09 | Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH | Pyrazolopyridine derivatives and their use in therapy |
| US9518057B2 (en) * | 2014-12-30 | 2016-12-13 | Novira Therapeutics, Inc. | Derivatives and methods of treating hepatitis B infections |
| AU2017290755B2 (en) * | 2016-06-29 | 2021-07-01 | Novira Therapeutics, Inc. | Diazepinone derivatives and their use in the treatment of hepatitis B infections |
| JP6935434B2 (ja) * | 2016-06-29 | 2021-09-15 | ノヴィラ・セラピューティクス・インコーポレイテッド | オキサジアゼピノン誘導体及びｂ型肝炎感染症の治療におけるその使用 |
-
2020
- 2020-05-27 CA CA3138168A patent/CA3138168A1/en active Pending
- 2020-05-27 BR BR112021022889A patent/BR112021022889A8/pt unknown
- 2020-05-27 SG SG11202113167QA patent/SG11202113167QA/en unknown
- 2020-05-27 JO JOP/2021/0313A patent/JOP20210313A1/ar unknown
- 2020-05-27 MA MA056043A patent/MA56043A/fr unknown
- 2020-05-27 WO PCT/US2020/034643 patent/WO2020243135A1/en active Application Filing
- 2020-05-27 EP EP20744199.9A patent/EP3976617A1/en active Pending
- 2020-05-27 AU AU2020285718A patent/AU2020285718A1/en active Pending
- 2020-05-27 CN CN202080039617.8A patent/CN113906028A/zh active Pending
- 2020-05-27 MX MX2021014575A patent/MX2021014575A/es unknown
- 2020-05-27 PE PE2021001959A patent/PE20220767A1/es unknown
- 2020-05-27 KR KR1020217042210A patent/KR20220012913A/ko active Search and Examination
- 2020-05-27 JP JP2021570274A patent/JP2022535734A/ja active Pending
- 2020-05-27 CR CR20210666A patent/CR20210666A/es unknown
-
2021
- 2021-11-23 IL IL288322A patent/IL288322A/en unknown
- 2021-11-26 CL CL2021003155A patent/CL2021003155A1/es unknown
- 2021-12-01 CO CONC2021/0016433A patent/CO2021016433A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102224081B1 (ko) | 치환된 피롤리진 화합물 및 그의 용도 | |
| CN111788204B (zh) | 作为hbv复制抑制剂的取代吡咯嗪化合物 | |
| KR102635333B1 (ko) | Pd-1/pd-l1 억제제 | |
| KR102369506B1 (ko) | Pd-1/pd-l1 억제제 | |
| CN111094242B (zh) | 用于治疗与nlrp活性相关的病症的化合物和组合物 | |
| TW201927766A (zh) | Hiv蛋白酶抑制劑 | |
| JP2020505396A5 (ru) | ||
| JP2011509309A5 (ru) | ||
| CA2969417A1 (en) | Bromodomain inhibitor as adjuvant in cancer immunotherapy | |
| JP2021532154A (ja) | 抗ｈｉｖ化合物 | |
| JP2014508720A5 (ru) | ||
| TWI846853B (zh) | 吡咯化合物 | |
| JP2019507114A5 (ru) | ||
| TW201245144A (en) | Novel compounds useful for the treatment of metabolic and inflammatory diseases | |
| JPWO2020243135A5 (ru) | ||
| JP2006219480A (ja) | アシルアミノチアゾール誘導体を有効成分とする医薬組成物 | |
| JP2023505703A (ja) | Ｌｐａ受容体２阻害剤としての芳香族アミド誘導体 | |
| JPWO2019213570A5 (ru) | ||
| CN114746425A (zh) | 作为lpa受体2抑制剂的噻吩并嘧啶衍生物 | |
| JPWO2021214117A5 (ru) | ||
| RU2021136240A (ru) | Сочлененные гетероциклические производные | |
| US20230133504A1 (en) | Method of treating graft-versus-host disease | |
| RU2021138956A (ru) | Сочлененные гетероциклические производные в качестве противовирусных средств | |
| KR20220017942A (ko) | Pdl1 체크포인트 억제제로서의 헤테로고리 면역조절제 |